Advertisement
Screener

ARVINAS, INC. (ARVN) Net Margin

ARVINAS, INC. (ARVN) Net Margin

  • 2026-06-30: Net Margin 67.84%.
  • 2026-03-31: Net Margin -369.23%.
  • 2025-12-31: Net Margin -709.47%.
  • 2025-09-30: Net Margin -83.77%.

Complete source-backed net margin history.

Available history
2017-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3067.84%
2026-03-31-369.23%
2025-12-31-709.47%
2025-09-30-83.77%
2025-06-30-273.21%
2025-03-3143.91%
2024-12-31-76.18%
2024-09-30-48.05%
2024-06-30-46.01%
2024-03-31-274.31%
2023-12-31359.16%
2023-09-30-184.97%
2023-06-30-122.20%
2023-03-31-252.00%
2022-12-31-219.31%
2022-09-30-199.40%
2022-06-30-207.10%
2022-03-31-239.25%
2021-12-31-200.76%
2021-09-30-503.23%
2021-06-30-914.55%
2021-03-31-745.45%
2020-12-31-1804.97%
2020-09-30-405.70%
2020-06-30-438.90%
2020-03-31-350.63%
2019-12-31-429.70%
2019-09-30-58.82%
2019-06-30-427.35%
2019-03-31-360.11%
2018-12-31-473.17%
2018-09-30-396.64%
2018-06-30-231.02%
2018-03-31-101.02%
2017-12-31-183.81%
2017-09-30-383.33%

Annual Net Margin

DateNet Margin
2025-12-31-30.77%
2024-12-31-75.51%
2023-12-31-467.90%
2022-12-31-214.99%
2021-12-31-408.99%
2020-12-31-547.25%
2019-12-31-384.15%
2018-12-31-290.07%
2017-12-31-317.32%

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Evolus, Inc. (EOLS)United States$0.519B-13.32
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85